1. Home
  2. Companies
  3. RAC
  4. Announcements

Racura Oncology (ASX:RAC)

ASX announcement history & article coverage

42
Total announcements
(in last 3 months)
6
With article
36
No article
Article coverage
14%
Transparent by design. Announcments by Racura Oncology (ASX:RAC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

13 July 2026 · 08:57 am AEST ASX Filing
Notification of cessation of securities - RAC
Appendix 3H (Notification of cessation of securities)
9 July 2026 · 10:42 am AEST ASX Filing
Racura to Present CPACS Data at GCOS 2026
Progress Report
6 July 2026 · 12:38 pm AEST ASX Filing
Racura Oncology New Zealand Investor Events
Web Cast
3 July 2026 · 08:46 am AEST ⚡ Price SensitiveMaterial ASX Filing
Bellberry Ethics Approval Activates New HARNESS Trial Sites
Bellberry Ethics Approval Enables Expansion of Racura's HARNESS-1 Lung Cancer Trial Sites
Progress Report
70
Bellberry Approval Unlocks New Sites for Racura’s HARNESS-1 Lung Cancer Trial Healthcare Wrap - Week 27 (29 June -> 3 July) 2026 Wrap
2 July 2026 · 08:29 am AEST ASX Filing
Notification of cessation of securities - RAC
Appendix 3H (Notification of cessation of securities)

25 June 2026 · 08:55 am AEST ⚡ Price SensitiveMaterial ASX Filing
Racura Treats First Patient in HARNESS-1 Lung Cancer Trial
Racura Oncology Treats First Patient in Phase 1 HARNESS-1 Lung Cancer Trial
Progress Report
65
16 June 2026 · 12:54 pm AEST ASX Filing
Racura Oncology Investor Briefings Perth & Auckland
Company Administration - Other
16 June 2026 · 12:36 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Racura raised $34.3m to Advance Three Oncology Trials
Racura Oncology Raises $34.3 Million to Fund Three Oncology Clinical Trials
Progress Report
85
Racura Oncology Secures $34.3 Million to Fully Fund Three Cancer Trials Market Wrap - Week 25 (15 June -> 19 June) 2026 Wrap Healthcare Wrap - Week 25 (15 June -> 19 June) 2026 Wrap
16 June 2026 · 12:33 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
16 June 2026 · 12:27 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
11 June 2026 · 02:50 pm AEST ASX Filing
Cleansing Notice
Cleansing Notice
11 June 2026 · 02:49 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
9 June 2026 · 08:48 am AEST ASX Filing
Appendix 3Y-Dr Serge Scrofani
Change of Director's Interest Notice
4 June 2026 · 12:02 pm AEST ASX Filing
Racura Options Raised $24.4m
Issued Capital - Other
4 June 2026 · 11:57 am AEST ASX Filing
Notification of cessation of securities - RAC
Appendix 3H (Notification of cessation of securities)
4 June 2026 · 08:52 am AEST ASX Filing
Proposed issue of securities - RAC
Appendix 3B (Proposed issue of securities)
4 June 2026 · 08:50 am AEST ⚡ Price SensitiveMaterial ASX Filing
Emerging Companies Specialist Invests in Racura
Racura Oncology raises $31.2 million including $1 million private placement to specialist investor
Placement
70
Racura Oncology Raises $31.2 Million Including $1 Million Institutional Placement Healthcare Wrap - Week 23 (1 June -> 5 June) 2026 Wrap
1 June 2026 · 03:40 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A

29 May 2026 · 02:50 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
28 May 2026 · 04:43 pm AEST ASX Filing
Proposed issue of securities - RAC
Appendix 3B (Proposed issue of securities)
28 May 2026 · 04:43 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Racura Enters Underwriting Agreement for Options
Racura Oncology secures underwriting for expiring options raising up to $2.3 million to support clinical programs
Issued Capital - Other
70
Racura Oncology Secures $2.3m Underwriting for Expiring Options to Boost Clinical Trials Healthcare Wrap - Week 22 (25 May -> 29 May) 2026 Wrap
28 May 2026 · 12:12 pm AEST ASX Filing
Appendix 3Y - Dr Daniel Tillett
Change of Director's Interest Notice
28 May 2026 · 12:07 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
26 May 2026 · 01:21 pm AEST ASX Filing
Appendix 3Y - Dr Daniel Tillett
Change of Director's Interest Notice
26 May 2026 · 01:18 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
21 May 2026 · 01:15 pm AEST ASX Filing
Appendix 3Y - Dr Daniel Tillett
Change of Director's Interest Notice
21 May 2026 · 01:12 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
21 May 2026 · 09:34 am AEST ASX Filing
Racura Oncology Final Option Expiry Reminder
Issued Capital - OtherCompany Administration - Other
15 May 2026 · 09:04 am AEST ⚡ Price SensitiveMaterial ASX Filing
CPACS Trial Cleared to Escalate to Next RC220 Dose Level
Racura Oncology clears dose escalation in Phase 1 CPACS trial for RC220
Progress Report
70
14 May 2026 · 12:56 pm AEST ASX Filing
Appendix 3Y - Dr Daniel Tillett
Change of Director's Interest Notice
14 May 2026 · 12:50 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
8 May 2026 · 09:08 am AEST ASX Filing
Racura Oncology Options Expiry Reminder
Issued Capital - OtherCompany Administration - Other
7 May 2026 · 12:10 pm AEST ASX Filing
Appendix 3Y - Dr Daniel Tillett
Change of Director's Interest Notice
7 May 2026 · 12:07 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
4 May 2026 · 01:04 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A

30 Apr 2026 · 01:24 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
30 Apr 2026 · 08:50 am AEST ⚡ Price SensitiveMaterial ASX Filing
March 2026 Quarterly Activity Report and Appendix 4C
Racura Oncology advances clinical trials and research with strong cash position in Q3 FY2026
Commitments Test Entity - Third Quarter Activity ReportTop 20 shareholders
80
Racura Oncology Advances Lung Cancer Trials with Strong Cash Backing Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026 Wrap
29 Apr 2026 · 09:10 am AEST ASX Filing
Racura and Wollongong Uni Granted NSW TechVoucher
Company Administration - Other
24 Apr 2026 · 10:40 am AEST ASX Filing
Notification of cessation of securities - RAC
Appendix 3H (Notification of cessation of securities)
23 Apr 2026 · 12:42 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A
22 Apr 2026 · 11:13 am AEST ⚡ Price SensitiveMaterial ASX Filing
Racura presents MYC silencing data at AACR 2026
Racura Oncology presents data showing (E,E)-bisantrene silences MYC gene at AACR 2026
Progress Report
75
Racura Oncology Unveils Mechanism Behind MYC Gene Silencing by (E,E)-bisantrene at AACR 2026 Healthcare Wrap - Week 17 (20 Apr -> 24 Apr) 2026 Wrap
16 Apr 2026 · 12:21 pm AEST ASX Filing
Application for quotation of securities - RAC
Appendix 2A